Subjective and Objective Cancer‐Related Cognitive Impairments Among Systemic and Radiation Therapy‐Naïve Female Cancer Patients
Субъективные и объективные когнитивные нарушения, связанные с раком, у пациенток с онкологическими заболеваниями, ранее не получавших системную или лучевую терапию
2025-04-01
SCID: 54.1/zupg6wum
Discuss with AI
FACT-Cogbreast and gynecological cancercancer-related cognitive impairmentneuropsychological testssubjective cognitive function
Figures from the paper
Abstract (AI)
BACKGROUND: Cancer-related cognitive impairment (CRCI) is a frequent and burdensome problem that is still insufficiently understood and managed. We investigated subjective and objective measures of CRCI, as recommended by the International Cancer and Cognition Task Force (ICCTF) in cancer patients prior to systemic or radiation therapy with respect to potential influencing or associated psychosocial, demographic, or lifestyle factors. METHODS: Female patients with breast or gynecological tumors (n = 239, mean age = 55.5, SD = 11.6) prior to any systemic or radiation therapy completed validated subjective (FACT-Cog: perceived cognitive impairment [PCI], perceived cognitive ability [PCA], impact on quality of life [IQoL]) and objective measures of CRCI (Trail Making Test [TMT-A and -B], Controlled Oral Word Association Test [COWA], and Hopkins Verbal Learning Test-Revised [HVLT-R]). Association with cross-sectionally assessed age, body mass index, education, smoking, alcohol intake, sleep problems, social support, anxiety, and pain was investigated using multiple linear regression models. RESULTS: A quarter (25.1%) of patients showed indication for CRCI based on the PCI score. Subjective and objective CRCI measures showed no or only weak correlations, also when adjusting for age and education (partial Spearman correlations with each other, all |r| ≤ 0.21). Anxiety, sleep problems, and pain were significantly associated with low subjective cognitive function (PCI, PCA, and IQoL). Poor objective cognitive values (TMT, COWA, and HVLT-R) were mainly determined by higher age and lower education. CONCLUSIONS: Cancer-related cognitive impairment is not solely (chemo-)therapy-induced but may be triggered or influenced by anxiety, sleep problems, and pain. Addressing these issues early in the treatment phase could potentially alleviate perceived CRCI. The ICCTF-recommended neuropsychological tests do not adequately capture this CRCI prior to systemic or radiation therapy, but could serve as complementary tools to monitor cognitive changes over time, independent of psychosocial influences.
Key Findings
1
Among 239 female breast or gynecological cancer patients before systemic or radiation therapy, 25.1% showed subjective cognitive impairment based on the FACT-Cog PCI score.
2
Anxiety, sleep problems, and pain were significantly associated with poorer subjective cognitive function and greater quality-of-life impact.
3
Cancer-related cognitive impairment may occur before therapy and is not solely treatment-induced; the recommended neuropsychological tests may inadequately capture pre-treatment subjective impairment.
4
Objective cognitive performance was primarily associated with older age and lower educational attainment.
5
Subjective and objective cognitive measures were uncorrelated or only weakly correlated, including after adjustment for age and education (all absolute partial Spearman correlations ≤ 0.21).
Research Object
female cancer patients with breast or gynecological tumors prior to systemic or radiation therapy
Research Subject
subjective and objective cancer-related cognitive impairment and its psychosocial, demographic, and lifestyle-associated factors
Publication Details
Publication Date
2025-04-01
Journal
Publisher
ISSN
Cited by
13
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest